Cerebrolysin for delirium in ICU patients
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a medicine called Cerebrolysin to see if it helps reduce confusion and agitation (delirium) in patients who are critically ill and being treated in the ICU. It may be an option for you if you are over 18 and have delirium symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have symptoms of delirium (like confusion or agitation).
- You are in the Intensive Care Unit (ICU) for a critical illness.
- You are not pregnant.
- You do not have a traumatic brain injury.
- You do not have a neuroinflammatory condition (such as multiple sclerosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “delirium,” a sudden confusion that can happen during critical care, in people receiving ICU treatment for stroke. It includes both adults and children in specific ICU settings and may help clinicians better prevent or manage confusion during recovery.
This study tests if a noninvasive brain stimulation technique called theta burst stimulation can improve thinking and memory problems that can happen after a stay in the ICU with delirium. It may help people who are still having cognitive issues a few months after leaving the hospital.
This pilot study tests a special brain monitor (called Ceribell EEG) to see if it can help detect delirium in ICU patients. Delirium is a state of confusion that can happen during a serious illness, and this monitor may help doctors catch it early.
This trial tests whether a gentle electrical current applied to the scalp can help treat delirium (sudden confusion) in intensive care patients. It aims to improve recovery in people who have had confusion for more than 24 hours.
This study tests a program that combines mental, social, and physical care to lower the risk of delirium (sudden confusion) in intensive care. It is for people who will be in the ICU for at least 15 days after certain brain conditions.
This trial tests whether a set of different care steps in the ICU can help prevent delirium, a sudden episode of confusion. It may help people who are at higher risk because they will likely need ICU care for more than a day.
Hear when a new Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.